A
Ahmedin Jemal
Researcher at American Cancer Society
Publications - 568
Citations - 492750
Ahmedin Jemal is an academic researcher from American Cancer Society. The author has contributed to research in topics: Cancer & Population. The author has an hindex of 132, co-authored 500 publications receiving 380474 citations. Previous affiliations of Ahmedin Jemal include Centers for Disease Control and Prevention & Emory University.
Papers
More filters
Journal ArticleDOI
Long-term survival of older breast cancer patients: population-based estimates over three decades
TL;DR: In this article, the authors compared trends in survival and stage distribution in the years 1977-1986, 1987-1996, and 1997-2006 in patients from 65 to 74, 75 to 84, and 85+ years of age.
Journal ArticleDOI
Heterogeneity of colon and rectum cancer incidence across 612 SEER counties, 2000-2014.
Pavel Chernyavskiy,Pavel Chernyavskiy,Victoria M. Kennerley,Ahmedin Jemal,Mark P. Little,Philip S. Rosenberg +5 more
TL;DR: Age‐period‐cohort analysis using 2000–2014 county‐level incidence from the Surveillance, Epidemiology, and End Results (SEER) database shows increasing colorectal cancer incidence in the younger age group is geographically widespread, although there is significant heterogeneity in temporal trends and risk both within and between states.
Journal ArticleDOI
State disparities in colorectal cancer rates: Contributions of risk factors, screening, and survival differences
Iris Lansdorp-Vogelaar,S. Lucas Goede,Jiemin Ma,Wu Xiau-Cheng,Karen Pawlish,Marjolein van Ballegooijen,Ahmedin Jemal +6 more
TL;DR: This study quantified how the disparities in CRC rates between Louisiana and New Jersey would be affected if differences in risk factors, screening, and stage‐specific CRC relative survival between the states were eliminated.
Journal ArticleDOI
Changes in treatment patterns for patients with locally advanced rectal cancer in the United States over the past decade: An analysis from the National Cancer Data Base (NCDB).
TL;DR: In this paper, the authors examined patterns of treatment for locally advanced rectal cancer in US over the past decade using the National Cancer Data Base (NCDB) and identified 66,197 patients diagnosed with stage II-III rectal adenocarcinoma and treated between 2004 and 2012.